Showing 11,941 - 11,960 results of 60,794 for search '(( 50 ((ns decrease) OR (a decrease)) ) OR ( 5 ((we decrease) OR (nn decrease)) ))', query time: 1.14s Refine Results
  1. 11941

    Table_3_Effects of transient, persistent, and resurgent sodium currents on excitability and spike regularity in vestibular ganglion neurons.pdf by Selina Baeza-Loya (20276955)

    Published 2024
    “…A known Na<sub>V</sub>1.6 channel blocker decreased spike rate and altered spike waveforms in both sustained and transient VGNs and affected all three modes of Na<sub>V</sub> current. …”
  2. 11942

    Table_1_Effects of transient, persistent, and resurgent sodium currents on excitability and spike regularity in vestibular ganglion neurons.pdf by Selina Baeza-Loya (20276955)

    Published 2024
    “…A known Na<sub>V</sub>1.6 channel blocker decreased spike rate and altered spike waveforms in both sustained and transient VGNs and affected all three modes of Na<sub>V</sub> current. …”
  3. 11943

    Image_3_Effects of transient, persistent, and resurgent sodium currents on excitability and spike regularity in vestibular ganglion neurons.pdf by Selina Baeza-Loya (20276955)

    Published 2024
    “…A known Na<sub>V</sub>1.6 channel blocker decreased spike rate and altered spike waveforms in both sustained and transient VGNs and affected all three modes of Na<sub>V</sub> current. …”
  4. 11944

    Image_1_Effects of transient, persistent, and resurgent sodium currents on excitability and spike regularity in vestibular ganglion neurons.pdf by Selina Baeza-Loya (20276955)

    Published 2024
    “…A known Na<sub>V</sub>1.6 channel blocker decreased spike rate and altered spike waveforms in both sustained and transient VGNs and affected all three modes of Na<sub>V</sub> current. …”
  5. 11945

    Image_4_Effects of transient, persistent, and resurgent sodium currents on excitability and spike regularity in vestibular ganglion neurons.pdf by Selina Baeza-Loya (20276955)

    Published 2024
    “…A known Na<sub>V</sub>1.6 channel blocker decreased spike rate and altered spike waveforms in both sustained and transient VGNs and affected all three modes of Na<sub>V</sub> current. …”
  6. 11946

    Table_6_Effects of transient, persistent, and resurgent sodium currents on excitability and spike regularity in vestibular ganglion neurons.pdf by Selina Baeza-Loya (20276955)

    Published 2024
    “…A known Na<sub>V</sub>1.6 channel blocker decreased spike rate and altered spike waveforms in both sustained and transient VGNs and affected all three modes of Na<sub>V</sub> current. …”
  7. 11947

    Table_2_Effects of transient, persistent, and resurgent sodium currents on excitability and spike regularity in vestibular ganglion neurons.pdf by Selina Baeza-Loya (20276955)

    Published 2024
    “…A known Na<sub>V</sub>1.6 channel blocker decreased spike rate and altered spike waveforms in both sustained and transient VGNs and affected all three modes of Na<sub>V</sub> current. …”
  8. 11948

    Table_4_Effects of transient, persistent, and resurgent sodium currents on excitability and spike regularity in vestibular ganglion neurons.pdf by Selina Baeza-Loya (20276955)

    Published 2024
    “…A known Na<sub>V</sub>1.6 channel blocker decreased spike rate and altered spike waveforms in both sustained and transient VGNs and affected all three modes of Na<sub>V</sub> current. …”
  9. 11949
  10. 11950

    Concurrent Treatment with Taxifolin and Cilostazol on the Lowering of β-Amyloid Accumulation and Neurotoxicity via the Suppression of P-JAK2/P-STAT3/NF-κB/BACE1 Signaling Pathways... by So Youn Park (141327)

    Published 2016
    “…Time-dependent increases in the expression of JAK2 phosphorylated at Tyr1007/1008 (P-JAK2) in activated N2a Swe cells. <b>C</b> and <b>D</b>. Concentration-dependent decreases in P-JAK2 expression by taxifolin (10 ~ 50 μM), cilostazol (10 ~ 50 μM), and 20 μM AG490 (a JAK2 inhibitor) determined after culture in medium containing 1% FBS for 3 hr. …”
  11. 11951
  12. 11952

    Data_Sheet_5_Construction and Analysis of a ceRNA Network in Cardiac Fibroblast During Fibrosis Based on in vivo and in vitro Data.PDF by Qing-Yuan Gao (10013927)

    Published 2021
    “…Finally, two mRNA [ADAM metallopeptidase domain 19, (ADAM19) and transforming growth factor beta induced, (TGFBI)], three microRNA (miR-9-5p, miR-124-3p, and miR-153-3p) and two lncRNA (LINC00511 and SNHG15) constituted our ceRNA network. siRNA against LINC00511 increased miR-124-3p and miR-9-5p expression, and decreased ADAM19 and TGFBI expression, whereas siRNA against SNHG15 increased miR-153-3p and decreased ADAM19 expression. …”
  13. 11953

    Image_2_CREB3L2 Modulates Nerve Growth Factor-Induced Cell Differentiation.JPEG by Luciana Sampieri (2922162)

    Published 2021
    “…Also, Rab5 immunofluorescence levels decrease in CREB3L2-depleted cells. …”
  14. 11954

    Image_3_CREB3L2 Modulates Nerve Growth Factor-Induced Cell Differentiation.JPEG by Luciana Sampieri (2922162)

    Published 2021
    “…Also, Rab5 immunofluorescence levels decrease in CREB3L2-depleted cells. …”
  15. 11955

    Image_1_CREB3L2 Modulates Nerve Growth Factor-Induced Cell Differentiation.JPEG by Luciana Sampieri (2922162)

    Published 2021
    “…Also, Rab5 immunofluorescence levels decrease in CREB3L2-depleted cells. …”
  16. 11956

    Data_Sheet_1_Testing Fmr1KO Phenotypes in Response to GSK3 Inhibitors: SB216763 versus AFC03127.PDF by Pamela R. Westmark (9302273)

    Published 2021
    “…<p>Glycogen synthase kinase 3 (GSK3) is a proline-directed serine-threonine kinase that is associated with several neurological disorders, including Alzheimer’s disease and fragile X syndrome (FXS). We tested the efficacy of a novel GSK3 inhibitor AFC03127, which was developed by Angelini Pharma, in comparison to the metabotropic glutamate receptor 5 inhibitor 2-Methyl-6-(phenylethynyl)pyridine hydrochloride (MPEP) and the GSK3 inhibitor SB216763 in in vivo and in vitro assays in Fmr1<sup>KO</sup> mice, a mouse model useful for the study of FXS. …”
  17. 11957
  18. 11958
  19. 11959
  20. 11960

    DataSheet_1_Antigenic Cross-Reactivity Between SARS-CoV-2 S1-RBD and Its Receptor ACE2.docx by Yen-Chung Lai (6480704)

    Published 2022
    “…However, the mechanisms through which these anti-ACE2 antibodies are induced during SARS-CoV-2 infection are unclear. In this study, we confirmed the increase in antibodies against ACE2 in patients with COVID-19 and found a positive correlation between the amounts of antibodies against ACE2 and S1-RBD. …”